

Overview
Metabolic syndrome (MetS) is a growing public health concern in Hong Kong, characterized by a cluster of interconnected cardiometabolic risk factors. It is a major driver of non-communicable diseases (NCDs) such as cardiovascular disease, stroke, and type 2 diabetes mellitus, which are leading causes of mortality worldwide. Given its rising prevalence and long-term clinical impact, primary care physicians play a crucial role in the early recognition and effective management of MetS.
Metabolic syndrome is diagnosed based on established clinical criteria that assess key cardiometabolic risk factors. According to the harmonized definition, MetS is present when any three of five risk factors are identified: elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein (HDL) cholesterol, elevated blood pressure, and elevated fasting glucose. In clinical practice, waist circumference is a practical marker of abdominal obesity with ethnicity-specific cut-offs being particularly important in Asian populations, including Hong Kong.
Metabolic syndrome management focuses on a comprehensive, patient-centered approach aimed at reducing overall cardiometabolic risk and preventing adverse health outcomes. Lifestyle modification remains the cornerstone of treatment and includes sustained weight reduction, regular physical activity, and adoption of healthy dietary patterns. Evidence-based dietary approaches such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension (DASH) diet have been shown to improve cardiometabolic risk factors. In addition to lifestyle interventions, targeted pharmacologic therapy may be required to address individual components of metabolic syndrome, including glucose-lowering agents for impaired glycemic control, lipid-lowering therapy for dyslipidemia, and antihypertensives for elevated blood pressure.
This e-learning module provides an overview of metabolic syndrome, its diagnostic criteria, underlying pathophysiology, clinical implications, and management in primary care. It emphasizes the importance of timely identification and risk reduction to prevent long-term complications. Equipped with these insights, primary care physicians are better positioned to integrate guideline-based strategies into routine practice and improve patient outcomes.
Upon completion of this module, learners should be able to:

Dr Anuradha Negi, MBBS MRCP [UK], FAMS [Singapore]
Senior Consultant, Raffles Hospital
Keywords: metabolic syndrome, metabolic syndrome criteria, cardiometabolic risk factors, metabolic syndrome management, cardiometabolic risk management